Voriconazole

Alphabetical Test listing

Voriconazole-13479

  
Voriconazole
  
13479
  
LAB13479
  
VOR
  
UK-109,496
Vfend
  

Treatment of invasive aspergillosis, esophageal candidiasis, candidemia, candida deep tissue infections or serious fungal infections caused by Scedosporium apiospermum and fusarium

  
Serum
  
  
1.0 mL
  
0.5 mL
  

Do not use a gel barrier tube. The use of gel-barrier tubes is not recommended due to slow absorption of the drug by the gel. Depending on the specimen volume and storage times, the decrease in drug level due to absorption may be clinically significant.

  
  1. Allow sample to clot
  2. Spin
  3. Transfer serum to a Transfer vial/tube with cap - 12mL (LabCorp), labelled as serum, within two (2) hours of sample collection
  
EDTA plasma
  
  

Immediately after collection, mix tube thoroughly by gentle inversion, 8 - 10 times, to prevent clotting

  
  1. Spin
  2. Transfer plasma to a Transfer vial/tube with cap - 12mL (LabCorp), labelled as EDTA plasma, within two (2) hours of sample collection
  

Refrigerated (preferred)

Ambient

Frozen

  
  • Gel barrier tubes
  
LabCorp Burlington (700353): R-LC
  
Mo - Fr
  
2 - 7 days
  

Liquid chromatography/tandem mass spectrometry (LC/MS-MS)

  

An interpretive report will be provided

  
Do not use a gel barrier tube.
The use of gel-barrier tubes is not recommended due to slow absorption of the drug by the gel. Depending on the specimen volume and storage times, the decrease in drug level due to absorption may be clinically significant.
  
80285
  
Result 38370-3
  
04/11/2019
  
01/02/2020